title: Placing a value on new technologies.
authors.forename: Paul A
authors.initials: PA
authors.lastname: Heidenreich
mesh_terms: D020517:Atrial Appendage; D001281:Atrial Fibrillation / Q000150:complications*; D001562:Benzimidazoles / Q000191:economics*; D054059:Coronary Occlusion / Q000191:economics*; D000069604:Dabigatran; D005260:Female; D006333:Heart Failure / Q000191:economics* / Q000628:therapy*; D016027:Heart Transplantation / Q000191:economics*; D006353:Heart-Assist Devices / Q000191:economics*; D006801:Humans; D008297:Male; D062645:Percutaneous Coronary Intervention / Q000191:economics*; D020521:Stroke / Q000191:economics* / Q000517:prevention & control*; D014180:Transplantation; D014859:Warfarin / Q000191:economics*; D015091:beta-Alanine / Q000031:analogs & derivatives* / Q000191:economics
chemical_list: D001562:Benzimidazoles; D015091:beta-Alanine; D014859:Warfarin; D000069604:Dabigatran
keywords: Editorials; atrial fibrillation; health care costs; heart failure; heart-assist devices